Cervical microbiome may promote high-grade precancerous lesions
Infections with a Human Papillomavirus (HPV) cause 99 percent of cervical cancer cases, and the…
Browsing: HPV
Gaps in health professionals’ knowledge about HPV and cervical screening
The first New Zealand study of health professionals’ knowledge and understanding about the human papillomavirus…
Self-testing cervical cancer screening could save Māori women’s lives
Cervical cancer is the second leading cause of cancer death for Māori women aged 25–44…
ESMO 2018: Patients with HPV-positive oropharynx cancer should receive chemoradiation
Patients with human papilloma virus (HPV)-positive throat cancer should receive chemoradiotherapy rather than cetuximab with…
Delay in replacing the Pap smear with HPV screening is costing lives
Alejandra Castanon, Queen Mary University of London It was established a decade ago that testing…
High-risk HPV linked to improved survival in cervical cancer
The presence of the human high-risk papillomavirus (hrHPV) in the diagnosis of invasive cervical cancer…
DNA vaccine leads to immune responses in HPV-related head and neck cancer
A therapeutic vaccine can boost antibodies and T cells, helping them infiltrate tumours and fight…
Treating skin cancer with HPV vaccines
Squamous cell carcinoma is the second-most-common form of skin cancer. Evidence suggests the human papilloma…
Cervical cancer may be driven by imbalance in vaginal bacteria, research finds
Virtually all cervical cancers are caused by HPV, or human papillomavirus, dubbed the “common cold”…
UK parents want the HPV vaccine for their sons – new research
Sue Sherman, Keele University Human papillomavirus (HPV) is a sexually transmitted infection that causes diseases…